Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.

HIV clinical trials - 1 Jan 2000

Lafeuillade Alain, Solas Caroline, Halfon Philippe, Chadapaud Stéphane, Hittinger Gilles, Lacarelle Bruno

Abstract excerpt

PURPOSE: To study the presence of three HIV-1 protease inhibitors (PIs) in the cerebrospinal fluid (CSF), semen, and lymph nodes and to assess the correlations with residual viral replication in these compartments. METHOD: We performed a cross-sectional analysis of sanctuary samples from 41 HIV-infected patients on stable highly active antiretroviral therapy (HAART) regimens containing indinavir, nelfinavir, or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to HIV Protease Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Indinavir

Share to Lopinavir

Share to Nelfinavir

Share to Pyrimidinones

Share to Ritonavir

Source

Identifiers

PMID: 11819183
DOI: 10.1310/WMWL-6W9Y-PXV2-X148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.PMID 11819183Read ↗

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.Semantic proximity Read ↗

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.Semantic proximity Read ↗

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapySemantic proximity Read ↗

Ongoing HIV replication in cerebrospinal fluid under successful monotherapy.Semantic proximity Read ↗

No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.Semantic proximity Read ↗

Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapySemantic proximity Read ↗

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapySemantic proximity Read ↗

Differential genotypic evolution of HIV-1 quasispecies in cerebrospinal fluid and plasma: a systematic review.Semantic proximity Read ↗

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.Semantic proximity Read ↗

HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimensSemantic proximity Read ↗

Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir.Semantic proximity Read ↗

Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.